Do you want to read an article? Please log in or register.
Improving efficiency of pediatric emergency asthma treatment by using metered dose inhaler
Related content
Co-suspension delivery technology in pressurized metered-dose inhalers for multi-drug dosing in the treatment of respiratory diseases
Respir Med.
Ferguson GT, Hickey AJ,
Dwivedi S
doi: 10.1016/j.rmed.
RECOMMENDED
AsthmaCOPD
Use and inhalation technique of inhaled medication in patients with asthma and COPD: data from a randomized controlled trial
Respir Res.
Gregoriano C, Dieterle T, Breitenstein AL, Dürr S, Baum A, Maier S, Arnet I, Hersberger KE, Leuppi JD
doi: 10.1186/s12931-018-0936-3.
RECOMMENDED
Asthma
Metered-dose inhalers vs. nebulization for the delivery of albuterol for acute exacerbations of wheezing or asthma in children: a systematic review with meta-analysis
★ 3
Recommended by
Dr Martin Frey, Faculty Member
Pediatr Pulmonol.
Payares-Salamanca L, Contreras-Arrieta S, Florez-García V, Barrios-Sanjuanelo A, Stand-Niño I, Rodriguez-Martinez CE
doi: 10.1002/ppul.25077.
RECOMMENDED
Further Publications
A new formulation of fluticasone propionate/salmeterol in a metered-dose inhaler (MDI HFA) allows for the reduction of a daily dose of corticosteroid and provides optimal asthma control - A randomized, multi-center, non-inferiority, phase IV clinical study
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Respir Med
Kupczyk M, Majak P, Kuna P, Asankowicz-Bargiel B, Barańska E, Dobek R, Garbicz S, Jerzyńska J, Latos A, Machowiak W, Majorek-Olechowska B, Olech-Cudzik A, Poziomkowska-Gęsicka I, Rulewicz-Warniełło M, Świderska A, Tarnowski M, Kopyto P
doi: 10.1016/j.rmed.2020.106274
Diagnosis and management of asthma - Statement on the 2015 GINA Guidelines
Horak F, Doberer D, Eber E, Horak E, Pohl W, Riedler J, Szépfalusi Z, Wantke F, Zacharasiewicz A, Studnicka M
Asthma
The pediatric asthma yardstick: practical recommendations for a sustained step-up in asthma therapy for children with inadequately controlled asthma
Ann Allergy Asthma Immunol.
Chipps BE, Bacharier LB, Farrar JR, Jackson DJ, Murphy KR, Phipatanakul W, Szefler SJ, Teague WG, Zeiger RS
doi: 10.1016/j.anai.2018.04.002.
RECOMMENDED
Asthma
A phase 3 study evaluating the safety and efficacy of a pediatric dose of mometasone furoate with and without formoterol for persistent asthma
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Pediatr Pulmonol.
Weinstein CLJ, Gates D, Zhang X, Varnell T, Mok W, Vermeulen JH, Amar NJ, Jain N
doi: 10.1002/ppul.24667.
RECOMMENDED
COPD
A phase III study of triple therapy with budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler 320/18/9.6 μg and 160/18/9.6 μg using co-suspension delivery technology in moderate-to-very severe COPD: The ETHOS study protocol
★ 1
Recommended by
Dr Martin Frey, Faculty Member
Respir Med.
Rabe KF, Martinez FJ, Ferguson GT, Wang C, Singh D, Wedzicha JA, Trivedi R, St Rose E, Ballal S, McLaren J, Darken P, Reisner C, Dorinsky P
doi: 10.1016/j.rmed.2019.08.010.
RECOMMENDED
Asthma
Reasons and outcomes for patients receiving ICS/LABA agents prior to, and one month after, emergency department presentations for acute asthma
J Asthma.
Villa-Roel C, Borgundvaag B, Majumdar SR, Emond M, Campbell S, Sivilotti M, Abu-Laban RB, Stiell IG, Aaron SD, Senthilselvan A, Rowe BH, AIR Investigators
doi: 10.1080/02770903.